These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 32767710)
1. The effect of concentrated pomegranate juice consumption on risk factors of cardiovascular diseases in women with polycystic ovary syndrome: A randomized controlled trial. Abedini M; Ghasemi-Tehrani H; Tarrahi MJ; Amani R Phytother Res; 2021 Jan; 35(1):442-451. PubMed ID: 32767710 [TBL] [Abstract][Full Text] [Related]
2. Effects of pomegranate juice consumption on blood pressure and lipid profile in patients with type 2 diabetes: A single-blind randomized clinical trial. Sohrab G; Roshan H; Ebrahimof S; Nikpayam O; Sotoudeh G; Siasi F Clin Nutr ESPEN; 2019 Feb; 29():30-35. PubMed ID: 30661697 [TBL] [Abstract][Full Text] [Related]
3. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome]. Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713 [TBL] [Abstract][Full Text] [Related]
4. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome. Song do K; Lee H; Sung YA; Oh JY Yonsei Med J; 2016 Nov; 57(6):1404-11. PubMed ID: 27593868 [TBL] [Abstract][Full Text] [Related]
5. The effect of synbiotics pomegranate juice on cardiovascular risk factors in PCOS patients: a randomized, triple-blinded, controlled trial. Esmaeilinezhad Z; Barati-Boldaji R; Brett NR; de Zepetnek JOT; Bellissimo N; Babajafari S; Sohrabi Z J Endocrinol Invest; 2020 Apr; 43(4):539-548. PubMed ID: 31713129 [TBL] [Abstract][Full Text] [Related]
6. Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia. Esmaillzadeh A; Tahbaz F; Gaieni I; Alavi-Majd H; Azadbakht L J Med Food; 2004; 7(3):305-8. PubMed ID: 15383223 [TBL] [Abstract][Full Text] [Related]
7. Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia. Esmaillzadeh A; Tahbaz F; Gaieni I; Alavi-Majd H; Azadbakht L Int J Vitam Nutr Res; 2006 May; 76(3):147-51. PubMed ID: 17048194 [TBL] [Abstract][Full Text] [Related]
8. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women? Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816 [TBL] [Abstract][Full Text] [Related]
9. Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome. Chang CY; Chen MJ; Yang WS; Yeh CY; Ho HN; Chen SU; Yang YS Taiwan J Obstet Gynecol; 2012 Dec; 51(4):583-90. PubMed ID: 23276562 [TBL] [Abstract][Full Text] [Related]
10. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
11. Effects of Pomegranate Juice on Cardiovascular Risk Factors in Patients with Metabolic Syndrome: a Double-Blinded, Randomized Crossover Controlled Trial. Moazzen H; Alizadeh M Plant Foods Hum Nutr; 2017 Jun; 72(2):126-133. PubMed ID: 28303364 [TBL] [Abstract][Full Text] [Related]
12. Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome? Erel CT; Senturk LM; Kaleli S; Gezer A; Baysal B; Tasan E Gynecol Endocrinol; 2003 Jun; 17(3):223-9. PubMed ID: 12857430 [TBL] [Abstract][Full Text] [Related]
13. Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Jamilian M; Foroozanfard F; Kavossian E; Aghadavod E; Shafabakhsh R; Hoseini A; Asemi Z Clin Nutr ESPEN; 2020 Apr; 36():128-133. PubMed ID: 32220355 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Legro RS; Kunselman AR; Dunaif A Am J Med; 2001 Dec; 111(8):607-13. PubMed ID: 11755503 [TBL] [Abstract][Full Text] [Related]
15. Value of the triglyceride-glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome. Zhang L; Wang H; Ma Q; Liu Y; Chen A; Lu J; Ren L Hormones (Athens); 2023 Jun; 22(2):263-271. PubMed ID: 36790635 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women. Kheirollahi A; Teimouri M; Karimi M; Vatannejad A; Moradi N; Borumandnia N; Sadeghi A Lipids Health Dis; 2020 Nov; 19(1):235. PubMed ID: 33161896 [TBL] [Abstract][Full Text] [Related]
17. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993 [TBL] [Abstract][Full Text] [Related]
18. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Holte J; Bergh T; Berne C; Lithell H Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457 [TBL] [Abstract][Full Text] [Related]
19. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589 [TBL] [Abstract][Full Text] [Related]
20. Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome. Rizzo M; Longo RA; Guastella E; Rini GB; Carmina E J Endocrinol Invest; 2011 Jun; 34(6):422-6. PubMed ID: 20959718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]